Galectin-3 for Thromboembolic Formation in Patients With Atrial Fibrillation CHA₂DS₂-VASc Scoring

Not yet recruiting

Phase N/A Results N/A

Summary of Purpose

Atrial Fibrillation is considered as one of a common cardiac arrhythmia that presented with rapid and irregular rhythm and has an increased incidence.There are different types of atrial fibrillation one of these is paroxysmal atrial fibrillation that defined as lasts longer than 30 seconds and lasting less than 7 days, while atrial fibrillation lasting more than 7 days to less than one year or requiring...

Read More →

Trial Milestones

The following dates are available for this trial. Trial information last updated on 22 January 2018.

1 Jun 2018 16 Jan 2018 1 Jun 2019 1 Jun 2020 1 Jan 2018 Unavailable
Start Date First Received 1st Completion Completion Verification Results

Trial Basics

Conditions

Sponsors

Trial Design

Not available

Contacts